This may be attributable to an interplay of factors, including immune dysfunction due to hyperglycemia in diabetic patients [23] and increase of the SARS-CoV-2 binding protein ACE2 in patients with hypertension or diabetes that are treated with ACE inhibitors and/or angiotensin II type-1 receptor blockers [24]. Here, ACE2 is linked to diabetes mellitus.